5585

543350

VIJAYA

img img img img
No Data Available

VIJAYA DIAGNOSTIC CEN LTD Share Price Update

As of the latest trading session, VIJAYA DIAGNOSTIC CEN LTD is trading at ₹1227.1, down by ₹-32.20 or -2.55% from its previous close. The stock has moved between ₹1221.40 and ₹1256.00 today. Over the past year, the stock has delivered a return of 34.82%. In the last month, it has returned 21.53%.

VIJAYA DIAGNOSTIC CEN LTD performance

Today’s low Today’s high
₹ 1221.40 ₹ 1256.00
₹ 1227.10
52 week low 52 week high
₹ 848.00 ₹ 1379.30
₹ 1227.10
Open Price ₹ 1255.00
Prev. Close ₹ 1259.30
Volume (Shares) 167296.00
Total traded value ₹ 2052.88
Upper Circuit ₹ 1511.10
Lower Circuit ₹ 1007.50
info

Investment Returns

Over 1 Month 21.53% Over 3 Months 24.30% Over 6 Months 25.00% Over 1 Year 34.82%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VIJAYA DIAGNOSTIC CEN LTD fundamentals


  • Market cap (Cr) 12,626.50
  • P/E Ratio (TTM) 72.66
  • Beta 0.42
  • Book Value / share 91.68
  • Return on equity 18.79%
  • EPS (TTM) 17.33
  • Dividend yield 0.16%
  • Net profit/quarter (Cr) 52.65
info icon alternate text
  • Market cap (Cr) 12,603.80
  • P/E Ratio (TTM) 72.66
  • Beta 0.31
  • Book Value / share 91.68
  • Return on equity 18.79%
  • EPS (TTM) 17.33
  • Dividend yield 0.16%
  • Net profit/quarter (Cr) 52.65
info icon alternate text

VIJAYA DIAGNOSTIC CEN LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 206.27
Operating Expense 145.23
Net Profit 52.65
Net Profit Margin (%) 25.52
Earnings Per Share (EPS) 5.12
EBITDA 98.42
Effective Tax Rate (%) 22.86
Particulars DEC 2025 (Values in Cr)
Revenue 193.08
Operating Expense 139.60
Net Profit 44.21
Net Profit Margin (%) 22.89
Earnings Per Share (EPS) 4.30
EBITDA 88.23
Effective Tax Rate (%) 25.10
Particulars SEP 2025 (Values in Cr)
Revenue 189.35
Operating Expense 137.45
Net Profit 42.70
Net Profit Margin (%) 22.55
Earnings Per Share (EPS) 4.15
EBITDA 83.66
Effective Tax Rate (%) 25.15
Particulars JUN 2025 (Values in Cr)
Revenue 176.73
Operating Expense 131.91
Net Profit 38.75
Net Profit Margin (%) 21.92
Earnings Per Share (EPS) 3.76
EBITDA 77.32
Effective Tax Rate (%) 25.55
Particulars MAR 2025 (Values in Cr)
Revenue 161.64
Operating Expense 120.55
Net Profit 33.42
Net Profit Margin (%) 20.67
Earnings Per Share (EPS) 3.23
EBITDA 69.28
Effective Tax Rate (%) 26.59
Particulars MAR 2026 (Values in Cr)
Revenue 765.43
Operating Expense 554.20
Net Profit 178.31
Net Profit Margin (%) 23.29
Earnings Per Share (EPS) 17.33
EBITDA 347.64
Effective Tax Rate (%) 24.56
Particulars MAR 2025 (Values in Cr)
Revenue 634.00
Operating Expense 468.97
Net Profit 135.93
Net Profit Margin (%) 21.44
Earnings Per Share (EPS) 13.23
EBITDA 272.17
Effective Tax Rate (%) 25.52
Particulars MAR 2024 (Values in Cr)
Revenue 525.02
Operating Expense 391.94
Net Profit 114.60
Net Profit Margin (%) 21.82
Earnings Per Share (EPS) 11.21
EBITDA 231.59
Effective Tax Rate (%) 24.83
Particulars MAR 2023 (Values in Cr)
Revenue 449.58
Operating Expense 352.88
Net Profit 83.23
Net Profit Margin (%) 18.51
Earnings Per Share (EPS) 8.16
EBITDA 193.54
Effective Tax Rate (%) 25.19
Particulars MAR 2022 (Values in Cr)
Revenue 450.88
Operating Expense 319.42
Net Profit 108.10
Net Profit Margin (%) 23.97
Earnings Per Share (EPS) 10.60
EBITDA 212.77
Effective Tax Rate (%) 25.12
Particulars MAR 2025 (Values in Cr)
Book Value / Share 77.53
ROE % 19.79
ROCE % 21.42
Total Debt to Total Equity 0.40
EBITDA Margin 41.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 64.21
ROE % 19.91
ROCE % 21.15
Total Debt to Total Equity 0.42
EBITDA Margin 42.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 53.37
ROE % 16.82
ROCE % 18.43
Total Debt to Total Equity 0.43
EBITDA Margin 42.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 45.92
ROE % 26.76
ROCE % 28.07
Total Debt to Total Equity 0.39
EBITDA Margin 46.83
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.22
ROE % 26.87
ROCE % 26.77
Total Debt to Total Equity 0.48
EBITDA Margin 47.20
Particulars MAR 2025 (Values in Cr)
Book Value / Share 76.34
ROE % 18.79
ROCE % 20.64
Total Debt to Total Equity 0.38
EBITDA Margin 41.67
Particulars MAR 2024 (Values in Cr)
Book Value / Share 63.83
ROE % 17.17
ROCE % 18.75
Total Debt to Total Equity 0.42
EBITDA Margin 39.79
Particulars MAR 2023 (Values in Cr)
Book Value / Share 53.40
ROE % 16.40
ROCE % 18.10
Total Debt to Total Equity 0.42
EBITDA Margin 43.05
Particulars MAR 2022 (Values in Cr)
Book Value / Share 46.09
ROE % 26.03
ROCE % 27.59
Total Debt to Total Equity 0.38
EBITDA Margin 47.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.56
ROE % 25.96
ROCE % 26.32
Total Debt to Total Equity 0.46
EBITDA Margin 47.41
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 48.87
Total Assets 1273.61
Total Liabilities 1273.61
Total Equity 799.14
Share Outstanding 10
Price to Book Ratio 13.19
Return on Assets (%) 11.23
Return on Capital (%) 17.9
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 73.07
Total Assets 982.75
Total Liabilities 982.75
Total Equity 659.91
Share Outstanding 10
Price to Book Ratio 9.95
Return on Assets (%) 12.09
Return on Capital (%) 18.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 116.42
Total Assets 853.40
Total Liabilities 853.40
Total Equity 546.63
Share Outstanding 10
Price to Book Ratio 7.33
Return on Assets (%) 9.91
Return on Capital (%) 15.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 192.35
Total Assets 713.46
Total Liabilities 713.46
Total Equity 469.54
Share Outstanding 10
Price to Book Ratio 9.50
Return on Assets (%) 15.37
Return on Capital (%) 23.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 194.24
Total Assets 541.24
Total Liabilities 541.24
Total Equity 359.23
Share Outstanding 4
Price to Book Ratio 0.00
Return on Assets (%) 15.60
Return on Capital (%) 23.23
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 41.19
Total Assets 1223.93
Total Liabilities 1223.93
Total Equity 783.52
Share Outstanding 10
Price to Book Ratio 13.19
Return on Assets (%) 11.03
Return on Capital (%) 17.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 62.01
Total Assets 962.13
Total Liabilities 962.13
Total Equity 653.32
Share Outstanding 10
Price to Book Ratio 9.95
Return on Assets (%) 11.91
Return on Capital (%) 17.54
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 111.42
Total Assets 850.06
Total Liabilities 850.06
Total Equity 545.08
Share Outstanding 10
Price to Book Ratio 7.33
Return on Assets (%) 9.79
Return on Capital (%) 15.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 186.05
Total Assets 710.83
Total Liabilities 710.83
Total Equity 469.98
Share Outstanding 10
Price to Book Ratio 9.50
Return on Assets (%) 15.20
Return on Capital (%) 23
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 188.54
Total Assets 533.15
Total Liabilities 533.15
Total Equity 360.54
Share Outstanding 4
Price to Book Ratio 0.00
Return on Assets (%) 15.53
Return on Capital (%) 22.97
Particulars MAR 2025 (Values in Cr)
Net Income 193.16
Cash from Operations 264.38
Cash from Investing -181.87
Cash from Financing -52.04
Net change in Cash -9.44
Free Cash Flow 359.94
Particulars MAR 2024 (Values in Cr)
Net Income 158.68
Cash from Operations 217.20
Cash from Investing -142.30
Cash from Financing -44.54
Net change in Cash -3.55
Free Cash Flow 305.16
Particulars MAR 2023 (Values in Cr)
Net Income 113.51
Cash from Operations 190.83
Cash from Investing -109.57
Cash from Financing -41.91
Net change in Cash 13.12
Free Cash Flow 315.67
Particulars MAR 2022 (Values in Cr)
Net Income 147.38
Cash from Operations 197.92
Cash from Investing -123.06
Cash from Financing -30.57
Net change in Cash 4.36
Free Cash Flow 320.27
Particulars MAR 2021 (Values in Cr)
Net Income 112.12
Cash from Operations 160.86
Cash from Investing -129.74
Cash from Financing -48.76
Net change in Cash -48.88
Free Cash Flow 192.99
Particulars MAR 2025 (Values in Cr)
Net Income 181.30
Cash from Operations 243.79
Cash from Investing -165.36
Cash from Financing -46.83
Net change in Cash -5.59
Free Cash Flow 316.81
Particulars MAR 2024 (Values in Cr)
Net Income 152.47
Cash from Operations 208.23
Cash from Investing -139.14
Cash from Financing -43.34
Net change in Cash -7.72
Free Cash Flow 294.15
Particulars MAR 2023 (Values in Cr)
Net Income 111.27
Cash from Operations 188.71
Cash from Investing -108.47
Cash from Financing -41.25
Net change in Cash 12.89
Free Cash Flow 313.16
Particulars MAR 2022 (Values in Cr)
Net Income 144.38
Cash from Operations 194.59
Cash from Investing -126.62
Cash from Financing -24.71
Net change in Cash 4.07
Free Cash Flow 316.69
Particulars MAR 2021 (Values in Cr)
Net Income 109.58
Cash from Operations 159.00
Cash from Investing -128.82
Cash from Financing -48.18
Net change in Cash -49.17
Free Cash Flow 190.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8304.10 61.04 12.60 119400.22 6680.00 8386.00
FORTIS MALAR HOSPITALS LIMITED 53.54 24.23 2.92 100.34 40.75 78.60
SHREE PACETRONIX LTD. 131.95 19.90 2.91 49.48 66.10 283.15
TRANSGENE BIOTEK LTD. 3.17 0.00 2.60 24.02 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8304.10 79.53 11.98 119400.22 6680.00 8386.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.50 0.00 -11.18 28.76 30.30 57.48
KOVAI MEDICAL CENTER & HO 5403.50 25.07 4.96 5911.43 5010.00 6725.00

VIJAYA DIAGNOSTIC CEN LTD shareholding pattern

Holding
4.17%
52.51%
13.37%
29.93%
1.48%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

VIJAYA DIAGNOSTIC CEN LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1227.10 -2.55 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 1278.60
  • 26 Days 1184.90
  • 10 Days 1266.50
  • 50 Days 1112.10
  • 12 Days 1256.90
  • 100 Days 1058.80
  • 20 Days 1213.40
  • 200 Days 1029.40
1271.77 PIVOT
First Support 1239.53 First Resistance 1291.53 Second Support 1219.77 Second Resistance 1323.77 Third Support 1187.53 Third Resistance 1343.53
RSI 62.40 ADX 73.77 MACD 72.00 Williams % R -49.32 Commodity Channel Index (CCI) 49.37
Date 2026-05-21 Week 128467.00 Same Day 45777.00 Month 175342.00
1 Year 0.43 3 Year 0.46
Over 1 Month
21.53% down
Over 1 Year
34.82% down
Over 3 Months
24.30% down
Over 3 Years
49.88% down
Over 6 Months
25.00% down
Over 5 Years
15.22% down

VIJAYA DIAGNOSTIC CEN LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
29 Aug 2025 2.0 Final 29 Aug 2025 Equity shares
30 Aug 2024 1.0 Final 30 Aug 2024 Equity shares
13 Sep 2023 1.0 Final 13 Sep 2023 Equity shares
20 Sep 2022 1.0 Final 21 Sep 2022 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
29 Aug 2025 2.0 Final 29 Aug 2025 Equity shares
30 Aug 2024 1.0 Final 30 Aug 2024 Equity shares
13 Sep 2023 1.0 Final 13 Sep 2023 Equity shares
20 Sep 2022 1.0 Final 21 Sep 2022 Equity shares

Top Gainers

Top Losers

VIJAYA DIAGNOSTIC CEN LTD Share Price

Vijaya Diagnostic Centre Limited established in 1981, is a leading provider of diagnostic services in India. With a steadfast commitment to delivering high quality, comprehensive diagnostic solutions, Vijaya has grown into the largest integrated diagnostic chain in Southern India. Founded by Dr. S. Surendranath Reddy, the journey began to offer reliable and comprehensive diagnostic services under one roof. Today, Company operate a vast network of 151+ diagnostic centres across 25+ cities, including Telangana, Andhra Pradesh, Maharashtra, Karnataka, West Bengal and the National Capital Region.

Their state-of-the-art facilities are equipped with the latest technology, to offer a wide range of pathology and radiology services. Company provides Corporate Wellness solutions. These corporate wellness solutions include onsite and offsite health check-ups. It works a corporate client base consisting of more than 450 multinational corporations operating in India. Corporate wellness solutions help ensure that a brand's workforce is always at the peak of its health, thereby enhancing business productivity.

Vijaya Diagnostic Centre Limited was incorporated as 'Vijaya Diagnostic Centre Private Limited' on June 5, 2002 as a Private Limited Company, which subsequently converted the status into a Public Company and the name of the Company was changed to Vijaya Diagnostic Centre Limited on 26 March, 2021.

The company came out with an Rs 1895.04-crore public issue during the month of September 2021, comprised 35688064 equity shares of Re 1 each at a price of Rs 531 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 14 September 2021.

The Company became first independent diagnostic centre in Telangana to get Revolution ACT 50 slice CT from Wipro GE Healthcare Private Limited in 2021. It opened 15 centres in 2021-22.

In 2023-24, Company acquired 100% equity stake in P H Diagnostic Centre Private Limited making it a wholly owned subsidiary of the Company effective from December 21, 2023. In Pune, the acquisition of P.H. Diagnostics enabled rapid scale-up through its wide range of centres. Company launched 2 new centres in Bengaluru in FY 2025. It operationalized first state-of-the-art-centre in Ambegaon, Pune under the brand name Vijaya-PH in FY 2025.

Medinova Diagnostic Services Limited (MDSL) has been merged with the Company in June, 2024.

Parent organization Indian Private
NSE symbol VIJAYA
Founded 2002
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vijaya Diagnostic Centre Ltd?

Answer Field

Vijaya Diagnostic Centre Ltd share price is for NSE ₹ 1,227.10 & for BSE ₹ 1,221.50 as on May 22 2026 03:30 PM.

What is the Market Cap of Vijaya Diagnostic Centre Ltd Share?

Answer Field

The market cap of Vijaya Diagnostic Centre Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 22 2026 03:30 PM.

What is the 52 Week High and Low of Vijaya Diagnostic Centre Ltd?

Answer Field

The 52 Week High and Low of Vijaya Diagnostic Centre Ltd for NSE is ₹ 1,379.30 and ₹ 848.00 and for BSE is ₹ 1,376.25 and ₹ 847.90.

What is 1 year return for Vijaya Diagnostic Centre Ltd?

Answer Field

The 1 year returns on the stock has been 34.82%.

What is the P/E Ratio of Vijaya Diagnostic Centre Ltd Share?

Answer Field

As on May 22 2026 03:30 PM the price-to-earnings (PE) ratio for Vijaya Diagnostic Centre Ltd share is 72.66.

What is the PB ratio of Vijaya Diagnostic Centre Ltd Share?

Answer Field

As on May 22 2026 03:30 PM, the price-to-book (PB) ratio for Vijaya Diagnostic Centre Ltd share is 91.68.

How to Buy Vijaya Diagnostic Centre Ltd Share?

Answer Field

You can trade in Vijaya Diagnostic Centre Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vijaya Diagnostic Centre Ltd Share on Bajaj Broking App?

Answer Field

To buy Vijaya Diagnostic Centre Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vijaya Diagnostic Centre Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|